Loading...
Chemical structure of PKRA83

GC70984

PKRA83

Also known as (3R)-N-[(6-chloro-3,4-dihydro-2H-1,5-benzodioxepin-8-yl)methyl]-1-[(4-fluoro-3-methoxyphenyl)methyl]-N-(2-methylpropyl)pyrrolidine-3-carboxamide

PKRA83 (PKRA7) is a potent prokineticin (PK2) antagonist, which can compete for the binding of PK2 to its receptors PKR1 and PKR2

ChemicalCAS1233926-87-8MW505.02FormulaC27H34ClFN2O4
CAS number
1233926-87-8
Molecular weight
505.02
Formula
C27H34ClFN2O4
Solubility
DMSO ： 25 mg/mL (49·50 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
InChIKey
GZHUKRDKTDCKQD-OAQYLSRUSA-N
Catalogue number
GC70984
Brand
GLPBIO
Computed properties PubChem CID 66726148 · XLogP 5 · TPSA 51.2 Ų · H-bond donors 0
XLogP
5
TPSA
51.2 Ų
H-bond donors
0
H-bond acceptors
6
Rotatable bonds
8
Heavy atoms
35

SMILES CC(C)CN(CC1=CC2=C(C(=C1)Cl)OCCCO2)C(=O)[C@@H]3CCN(C3)CC4=CC(=C(C=C4)F)OC

Computed descriptors from PubChem (CID 66726148), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.